5AM Venture Management, LLC - Q4 2019 holdings

$465 Million is the total value of 5AM Venture Management, LLC's 9 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was - .

 Value Shares↓ Weighting
APRE NewAprea Therapeutics, Inc.$130,908,0002,852,654
+100.0%
28.17%
FIXX NewHomology Medicines, Inc.$114,594,0005,535,919
+100.0%
24.66%
CRNX NewCrinetics Pharmaceuticals, Inc.$59,270,0002,362,286
+100.0%
12.75%
ARVN NewArvinas, Inc.$56,639,0001,378,423
+100.0%
12.19%
CABA NewCabaletta Bio, Inc.$51,260,0003,669,263
+100.0%
11.03%
IDYA NewIDEAYA Biosciences, Inc.$25,973,0003,463,066
+100.0%
5.59%
SCPH NewscPharmaceuticals Inc.$18,414,0003,253,440
+100.0%
3.96%
CDTX NewCidara Therapeutics, Inc.$7,705,0002,006,511
+100.0%
1.66%
NewViveve Medical, Inc.$10,0008,078
+100.0%
0.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-02-05
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HOMOLOGY MEDICINES INC16Q3 202326.6%
ARVINAS INC16Q3 202314.3%
Crinetics Pharmaceuticals, Inc.16Q3 202312.8%
SCPHARMACEUTICALS INC16Q3 20237.5%
CIDARA THERAPEUTICS INC16Q3 20231.7%
IDEAYA BIOSCIENCES INC14Q1 202311.4%
VOR BIOPHARMA INC11Q3 202351.9%
CABALETTA BIO INC11Q2 202214.2%
AKOUOS INC10Q3 202227.7%
IMPEL PHARMACEUTICALS INC10Q3 20237.1%

View 5AM Venture Management, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-03
13F-HR2021-11-15

View 5AM Venture Management, LLC's complete filings history.

Compare quarters

Export 5AM Venture Management, LLC's holdings